Product Code: ETC7550230 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India pancreatic cancer therapeutics and diagnostics market import shipments demonstrated a moderate expansion with a CAGR of 3.0% from 2020 to 2024. Notably, there was a significant growth spurt of 26.5% between 2023 and 2024, indicating a surge in market momentum towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pancreatic Cancer Therapeutics and Diagnostics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pancreatic Cancer Therapeutics and Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 India Pancreatic Cancer Therapeutics and Diagnostics Market - Industry Life Cycle |
3.4 India Pancreatic Cancer Therapeutics and Diagnostics Market - Porter's Five Forces |
3.5 India Pancreatic Cancer Therapeutics and Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 India Pancreatic Cancer Therapeutics and Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of pancreatic cancer in India |
4.2.2 Advancements in diagnostic technologies leading to early detection and treatment |
4.2.3 Growing awareness about pancreatic cancer among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 High cost associated with pancreatic cancer therapeutics and diagnostics |
4.3.2 Limited availability and accessibility of specialized treatment centers |
4.3.3 Regulatory challenges and approval processes for new therapies |
5 India Pancreatic Cancer Therapeutics and Diagnostics Market Trends |
6 India Pancreatic Cancer Therapeutics and Diagnostics Market, By Types |
6.1 India Pancreatic Cancer Therapeutics and Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Pancreatic Cancer Therapeutics and Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Pancreatic Cancer Therapeutics and Diagnostics Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.4 India Pancreatic Cancer Therapeutics and Diagnostics Market Revenues & Volume, By Diagnostics, 2021- 2031F |
7 India Pancreatic Cancer Therapeutics and Diagnostics Market Import-Export Trade Statistics |
7.1 India Pancreatic Cancer Therapeutics and Diagnostics Market Export to Major Countries |
7.2 India Pancreatic Cancer Therapeutics and Diagnostics Market Imports from Major Countries |
8 India Pancreatic Cancer Therapeutics and Diagnostics Market Key Performance Indicators |
8.1 Survival rates of patients diagnosed with pancreatic cancer |
8.2 Adoption rates of innovative diagnostic technologies in the market |
8.3 Number of clinical trials and research studies conducted in the field of pancreatic cancer therapeutics and diagnostics |
9 India Pancreatic Cancer Therapeutics and Diagnostics Market - Opportunity Assessment |
9.1 India Pancreatic Cancer Therapeutics and Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
10 India Pancreatic Cancer Therapeutics and Diagnostics Market - Competitive Landscape |
10.1 India Pancreatic Cancer Therapeutics and Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 India Pancreatic Cancer Therapeutics and Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |